Coultreon Biopharma Appoints Prista Charuworn as Chief Medical Officer
Position
Chief Medical Officer
Company
Coultreon Biopharma
Description
Coultreon Biopharma announced the appointment of Prista Charuworn, MD, as Chief Medical Officer. Dr. Charuworn brings extensive immunology drug development experience to accelerate the clinical development of Coultreon's first-in-class SIK3 inhibitor COL-5671.
Quick answer
Coultreon Biopharma Appoints Prista Charuworn as Chief Medical Officer (August 18, 2026).
- Who is the new Chief Medical Officer at Coultreon Biopharma?
- Coultreon Biopharma named Prista Charuworn Chief Medical Officer, announced August 18, 2026.
- What did Coultreon Biopharma announce on August 18, 2026?
- Coultreon Biopharma announced the appointment of Prista Charuworn, MD, as Chief Medical Officer. Dr. Charuworn brings extensive immunology drug development experience to accelerate the clinical development of Coultreon's first-in-class SIK3 inhibitor COL-5671.
- Where did Prista Charuworn work before joining Coultreon Biopharma?
- Prista Charuworn joins from Zai Lab.
- What does Coultreon Biopharma do?
- Coultreon Biopharma, formerly known as Onco3R Therapeutics, is a biotechnology company based in Leuven, Belgium.
- Which similar companies made leadership changes around the same time?
- Nurix Therapeutics (August 21, 2026), Neumora (August 14, 2026), Olema Oncology (August 14, 2026) and Olema Oncology, Inc. (August 13, 2026) also announced leadership changes within 45 days of Coultreon Biopharma.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Nurix Therapeutics Appoints Wes Burwell as Chief Human Resources Officer (August 21, 2026)
- Neumora Therapeutics Names Joshua Pinto, Ph.D. as Chief Executive Officer (August 14, 2026)
- Olema Oncology Appoints Jason O’Byrne as Chief Financial Officer (August 14, 2026)
- Olema Pharmaceuticals Appoints Jason O’Byrne as Chief Financial Officer (August 13, 2026)
- EIT Pharma Appoints Dr. Leen Kawas as Chief Executive Officer (August 12, 2026)
- Leigh Steinberg Appointed as Class II Director at FibroBiologics (August 24, 2026)
Who to call at Coultreon Biopharma, and when
A new leader at Coultreon Biopharma brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Coultreon Biopharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Coultreon Biopharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Coultreon Biopharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Coultreon Biopharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Coultreon Biopharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.